Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years.
Saved in:
| Title: | Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years. |
|---|---|
| Authors: | Mitha E; Newtown Clinical Research Centre, Johannesburg, South Africa., Ferguson M; Colchester Research Group, Truro, Canada., Wilhase AC; REIMED Pty., Boksburg, South Africa., De Looze F; Momentum Clinical Research Wellers Hill, Brisbane, Australia., Vachon ML; Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec, Canada., Stacey H; Diablo Clinical Research, Walnut Creek, California, USA., Rasalam R; Momentum Clinical Research Sunshine, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Nozaki M; Shirayurikai Swing Nozaki Clinic, Tokyo, Japan., Smith WB; AMR Clinical, Knoxville, Tennessee, USA., Schwarz TF; Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Juliusspital, Würzburg, Germany., Hailemariam HA; GSK, Wavre, Belgium., Deraedt Q; GSK, Wavre, Belgium., Gérard C; GSK, Rixensart, Belgium., Vanden Abeele C; GSK, Wavre, Belgium., Damaso S; GSK, Wavre, Belgium., Descamps D; GSK, Wavre, Belgium., Hill J; GSK, Wavre, Belgium., Dasyam D; GSK, Wavre, Belgium., Van Gucht J; GSK, Wavre, Belgium., Hulstrøm V; GSK, Wavre, Belgium. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 May 20; Vol. 82 (5), pp. e1093-e1103. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41757519 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mitha+E%22">Mitha E</searchLink>; Newtown Clinical Research Centre, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Ferguson+M%22">Ferguson M</searchLink>; Colchester Research Group, Truro, Canada.<br /><searchLink fieldCode="AU" term="%22Wilhase+AC%22">Wilhase AC</searchLink>; REIMED Pty., Boksburg, South Africa.<br /><searchLink fieldCode="AU" term="%22De+Looze+F%22">De Looze F</searchLink>; Momentum Clinical Research Wellers Hill, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Vachon+ML%22">Vachon ML</searchLink>; Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Stacey+H%22">Stacey H</searchLink>; Diablo Clinical Research, Walnut Creek, California, USA.<br /><searchLink fieldCode="AU" term="%22Rasalam+R%22">Rasalam R</searchLink>; Momentum Clinical Research Sunshine, Melbourne, Australia.; University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Nozaki+M%22">Nozaki M</searchLink>; Shirayurikai Swing Nozaki Clinic, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Smith+WB%22">Smith WB</searchLink>; AMR Clinical, Knoxville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Schwarz+TF%22">Schwarz TF</searchLink>; Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Juliusspital, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hailemariam+HA%22">Hailemariam HA</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Deraedt+Q%22">Deraedt Q</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Gérard+C%22">Gérard C</searchLink>; GSK, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Vanden+Abeele+C%22">Vanden Abeele C</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Damaso+S%22">Damaso S</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Descamps+D%22">Descamps D</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Hill+J%22">Hill J</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Dasyam+D%22">Dasyam D</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Gucht+J%22">Van Gucht J</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Hulstrøm+V%22">Hulstrøm V</searchLink>; GSK, Wavre, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2026 May 20; Vol. 82 (5), pp. e1093-e1103. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase III; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41757519 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciag058 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1093 Titles: – TitleFull: Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mitha E – PersonEntity: Name: NameFull: Ferguson M – PersonEntity: Name: NameFull: Wilhase AC – PersonEntity: Name: NameFull: De Looze F – PersonEntity: Name: NameFull: Vachon ML – PersonEntity: Name: NameFull: Stacey H – PersonEntity: Name: NameFull: Rasalam R – PersonEntity: Name: NameFull: Nozaki M – PersonEntity: Name: NameFull: Smith WB – PersonEntity: Name: NameFull: Schwarz TF – PersonEntity: Name: NameFull: Hailemariam HA – PersonEntity: Name: NameFull: Deraedt Q – PersonEntity: Name: NameFull: Gérard C – PersonEntity: Name: NameFull: Vanden Abeele C – PersonEntity: Name: NameFull: Damaso S – PersonEntity: Name: NameFull: Descamps D – PersonEntity: Name: NameFull: Hill J – PersonEntity: Name: NameFull: Dasyam D – PersonEntity: Name: NameFull: Van Gucht J – PersonEntity: Name: NameFull: Hulstrøm V IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 05 Text: 2026 May 20 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 82 – Type: issue Value: 5 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |